MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Association between lifestyle and environmental factors with disease severity and age at onset in multi-ethnic Malaysian Parkinson’s disease patients

    JP. Schee, HC. Ting, ZL. Loo, AMF. Dy Closas, TS. Toh, JW. Hor, YW. Tay, JL. Lim, LC. Lit, AH. Tan, SY. Lim (Kuala Lumpur, Malaysia)

    Objective: We explored the association between self-reported exposure to caffeine, smoking, and environmental toxins (pesticides, chemical solvents, heavy metals, other chemicals, and fumes) with Aao…
  • 2023 International Congress

    Flavonoid intake and risk of Parkinson’s Disease

    H. Sandoval Insausti, K. Bjornevik, J. Chavarro, M. Cortese, M. Flores, A. Hung, M. Schwarzschild, T. Yeh, A. Ascherio (Boston, USA)

    Objective: To prospectively examine the association between the intake of flavonoids and their subclasses (flavanones, anthocyanins, flavan-3-ols, flavonols, flavones, and polymers) and the risk of…
  • 2023 International Congress

    Sex-specific speech correlates of dysphagia in Parkinson’s disease

    JH. Ahn, D. Shin, MK. Suh, YE. Huh, J. Youn, JW. Cho, JS. Lee (Seoul, Republic of Korea)

    Objective: To identify speech characteristics that directly correlate with dysphagia in advanced Parkinson's disease (PD) patients, using both acoustic and perceptual analyses of speech, with…
  • 2023 International Congress

    Familial Parkinson’s: Epidemiological data at Blida University Hospital.

    M. Benmahdjoub, K. Kesraoui, S. Bouchetara, M. Arezki (Blida, Algeria)

    Objective: In Algeria, few epidemiological data published on PD. The objective of this work is to study the epidemiological aspects of familial parkinson (PF) at…
  • 2023 International Congress

    ‘That dark place’ – A thematic exploration of why people with Parkinson’s living in the UK, may, at times, experience suicidal ideation, as conveyed through an internet Forum

    E. Edwards (Plymouth, United Kingdom)

    Objective: This study aims to understand what may lead a person with Parkinson’s (PwP) to experience suicidal thoughts. Better knowledge on the subject could lead…
  • 2023 International Congress

    Selegiline drives autophagic secretion of α-synuclein

    Y. Nakamura, S. Arawaka (Takatsuki, Japan)

    Objective: Our aim is to elucidate how selegiline drives extracellular secretion of α-synuclein (αS) and whether selegiline-induced αS secretion affects cell-to-cell transmission of αS. Background:…
  • 2023 International Congress

    User Experience (UX): Successful Remote Engagement Strategy for Individuals at Risk for Parkinson’s Disease in PPMI

    L. Lemon, R. Dobkin, M. Kuhl, K. Fabrizio, C. Stanley, L. Heathers, C. Hobbick, B. Mcmahon, M. Totten, K. Marek (New Haven, USA)

    Objective: Describe participant engagement practices for progressive User Experience (UX) in a remote risk screening study. Background: Digital instruments continue to gain footing in clinical…
  • 2023 International Congress

    A Comparison of Cervical Dystonia in Parkinson’s Disease and Idiopathic Isolated Cervical Dystonia

    L. Higginbotham, S. Perez Parra, L. Scorr, H. Jinnah, S. Factor (Atlanta, USA)

    Objective: To perform a prospective analysis of the prevalence and clinical characteristics of cervical dystonia in Parkinson’s disease (CD-PD) and compare these features to those…
  • 2023 International Congress

    Validation of the Patient Reported Outcomes in Parkinson’s Disease scale in outpatients

    D. von Below, S. Wallerstedt, F. Bergquist (Gothenburg, Sweden)

    Objective: To validate PRO-PD in a random sample of outpatients with PD. Background: Successful treatment of Parkinson's disease (PD) requires symptom monitoring. Patient-Reported Outcomes in…
  • 2023 International Congress

    Apomorphine effects on Parkinson’s disease fluctuation related pain: a pilot study

    P. Alizadeh, V. Bruno, K. Naser, A. Abusarair, B. Achen (Calgary, Canada)

    Objective: To evaluate the effect and safety of subcutaneous apomorphine as a treatment for fluctuation-related pain in Parkinson's disease (PD). Background: Pain is one of…
  • « Previous Page
  • 1
  • …
  • 149
  • 150
  • 151
  • 152
  • 153
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley